Catalyst Wire Dossier Catalyst Wire Dossier

Low-dose combined oral contraceptive (Pearl Index study)

· Bayer
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Low-dose combined oral contraceptive (Pearl Index study), covering 2015-04-03 to 2015-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Pearl Index Study With Low Dose Combined Oral Contraceptive [Phase 3]

See pricing